Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2)Meng Chai, Yong‐Ming He, Zhao Wang et al.|BMC Medicine|2023Cited by 50